BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12018565)

  • 1. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
    Iyer VK; Raina V; Dawar R
    Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
    Gan X
    Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.
    Crocker J; Egan MJ
    J Pathol; 1988 Nov; 156(3):233-9. PubMed ID: 3060577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
    Jakić-Razumović J; Petrovecki M; Dominis M
    Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
    Crocker J; Macartney JC; Smith PJ
    J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AgNOR in the pathologic differential diagnosis of tumors].
    Chen BF
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):463-6. PubMed ID: 1315672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
    Jakić-Razumović J; Labar B; Cör A; Radman I
    Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
    Mathur S; Dawar R; Verma K
    Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of nucleolar organiser regions in colorectal cancer: a 5-year follow-up study.
    Joyce WP; Fynes M; Moran KT; Gough DB; Dervan P; Gorey TF; Fitzpatrick JM
    Ann R Coll Surg Engl; 1992 May; 74(3):172-6; discussion 176-7. PubMed ID: 1616259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
    Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
    Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nucleolar organizer regions and mitotic activity in non-Hodgkin's lymphoma].
    Dubrovskiĭ ACh; Kliukina LB
    Arkh Patol; 1997; 59(1):25-30. PubMed ID: 9139602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organizer regions (NORs) in lymphoproliferative disorders of the human salivary gland.
    Takahashi H; Fujita S; Cheng J; Tsuda N; Tezuka F; Liu AR; Okabe H
    Anal Cell Pathol; 1994 Jan; 6(1):51-63. PubMed ID: 8130131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
    Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
    Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in lymphomas: a quantitative study.
    Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
    Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M; Menon M; Doctor V
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.